Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 8/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.38 |
| ▸ | MME | P08473 | 3/20 | 0.37 |
| ▸ | CALCR | P30988 | 4/20 | 0.37 |
| ▸ | APC | P25054 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29894779 | 0.92 | MME (0.46) | OPRD1OPRM1MME | |
| SCHEMBL30123343 | 0.86 | OPRD1 (0.47) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29895454 | 0.85 | ENPEP (0.43) | OPRD1OPRM1MME | |
| SCHEMBL29894761 | 0.84 | OPRD1 (0.42) | OPRD1OPRM1OPRK1MME | |
| SCHEMBL29587542 | 0.84 | OPRD1 (0.52) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30988398 | 0.84 | ACE (0.33) | OPRD1OPRM1OPRK1MME | |
| SCHEMBL30116291 | 0.83 | MME (0.38) | MME | |
| SCHEMBL21246653 | 0.81 | OPRD1 (0.42) | OPRD1OPRM1OPRK1 | |
| SCHEMBL416409 | 0.81 | OPRM1 (0.39) | OPRD1OPRM1OPRK1 | |
| SCHEMBL416410 | 0.81 | OPRM1 (0.39) | OPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |